Models based on dopaminergic neurons derived from Parkinson’s patient iPSCs have demonstrated higher α-synuclein protein levels and increased phosphorylation of α-synuclein at serine residue 129 (pS129) compared to controls [5, 6]. The gene discussed is SNCA; the disease is Parkinson disease.